1. Home
  2. MIST vs FNWD Comparison

MIST vs FNWD Comparison

Compare MIST & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • FNWD
  • Stock Information
  • Founded
  • MIST 2003
  • FNWD 1994
  • Country
  • MIST Canada
  • FNWD United States
  • Employees
  • MIST N/A
  • FNWD N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • FNWD Savings Institutions
  • Sector
  • MIST Health Care
  • FNWD Finance
  • Exchange
  • MIST Nasdaq
  • FNWD Nasdaq
  • Market Cap
  • MIST 132.5M
  • FNWD 121.8M
  • IPO Year
  • MIST N/A
  • FNWD N/A
  • Fundamental
  • Price
  • MIST $1.43
  • FNWD $27.52
  • Analyst Decision
  • MIST Strong Buy
  • FNWD Buy
  • Analyst Count
  • MIST 2
  • FNWD 1
  • Target Price
  • MIST $7.50
  • FNWD $34.00
  • AVG Volume (30 Days)
  • MIST 2.9M
  • FNWD 55.3K
  • Earning Date
  • MIST 08-15-2025
  • FNWD 07-29-2025
  • Dividend Yield
  • MIST N/A
  • FNWD 1.74%
  • EPS Growth
  • MIST N/A
  • FNWD N/A
  • EPS
  • MIST N/A
  • FNWD 1.24
  • Revenue
  • MIST N/A
  • FNWD $63,780,000.00
  • Revenue This Year
  • MIST N/A
  • FNWD N/A
  • Revenue Next Year
  • MIST N/A
  • FNWD $6.97
  • P/E Ratio
  • MIST N/A
  • FNWD $22.14
  • Revenue Growth
  • MIST N/A
  • FNWD N/A
  • 52 Week Low
  • MIST $0.63
  • FNWD $26.12
  • 52 Week High
  • MIST $2.75
  • FNWD $33.50
  • Technical
  • Relative Strength Index (RSI)
  • MIST 40.51
  • FNWD 47.01
  • Support Level
  • MIST $1.42
  • FNWD $27.11
  • Resistance Level
  • MIST $1.64
  • FNWD $28.99
  • Average True Range (ATR)
  • MIST 0.11
  • FNWD 0.99
  • MACD
  • MIST -0.03
  • FNWD 0.11
  • Stochastic Oscillator
  • MIST 8.95
  • FNWD 41.90

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

Share on Social Networks: